Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Breast Neoplasms 43Lung Neoplasms 29Neoplasms 25Colorectal Neoplasms 19Prostatic Neoplasms 12Uterine Cervical Neoplasms 9Fatigue 9Hematologic Neoplasms 8Anxiety Disorders 8Neoplasm Metastasis 7Hematopoietic and Lymphatic System Neoplasm 7Lymphoma 6Papillomavirus Infections 5Ovarian Neoplasms 5Multiple Myeloma 5Gastrointestinal Neoplasms 5Depression 5Obesity-Related Malignant Neoplasm 4Obesity 4Motor Activity 4Melanoma 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Carcinoma In Situ 4Triple Negative Breast Neoplasms 3Skin Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Malignant Solid Neoplasm 3

Interventions

Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Chemotherapy-Induced Peripheral Neuropathy × Educational Status × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡